Sumitomo Chemical India Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Sumitomo Chemical India (NSE:SUMICHEM) Second Quarter 2025 Results

Key Financial Results

• Revenue: ₹10.2b (up 13% from 2Q 2024).
• Net income: ₹1.92b (up 34% from 2Q 2024).
• Profit margin: 19% (up from 16% in 2Q 2024). The increase in margin was driven by higher revenue.
• EPS: ₹3.85 (up from ₹2.87 in 2Q 2024).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Sumitomo Chemical India EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 4.7%. Earnings per share (EPS) exceeded analyst estimates by 10%.

Looking ahead, revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India.

Performance of the Indian Chemicals industry.

The company's shares are up 10% from a week ago.

Balance Sheet Analysis

While earnings are important, another area to consider is the balance sheet. We've done some analysis and you can see our take on Sumitomo Chemical India's balance sheet.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.